During the past decade, Southampton General Hospital; Medical Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southampton General Hospital; Medical Oncology" #1 collaborator was "BioNTech SE" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Southampton General Hospital; Medical Oncology" are "Bladder Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Renal Cell Carcinoma" (2 trials), "Breast Cancer" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Southampton General Hospital; Medical Oncology" in a lesser frequency.

Most popular intervention types in "Southampton General Hospital; Medical Oncology" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Bevacizumab" (3 trials), "Vemurafenib" (2 trials), "5-FU/LV" (1 trials) and "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southampton General Hospital; Medical Oncology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Southampton General Hospital; Medical Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Southampton General Hospital; Medical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southampton General Hospital; Medical Oncology, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".